AI
Sunday, March 28, 2010 11:20:13 AM
12/17/09
Opexa Therapeutics Closes $5.1 Mln Registered Direct Offering - Quick Facts
(RTTNews) - Thursday, Opexa Therapeutics Inc. (OPXA) completed its registered direct offering with several institutional investors to sell 2.55 million units. Each unit consist of one share of Opexa common stock, a five-year Series A warrant to purchase 0.35 of an additional share of Opexa common stock, and a one-year Series B warrant to purchase 0.15 of an additional share of Opexa common stock.
The price of the securities sold was $2.00 per unit, for an aggregate purchase price of $5.1 million. Following to a securities purchase agreement between Opexa and the investors in this offering, the warrants are exercisable at $2.55 per share and are first exercisable on June 15, 2010. The Series A Warrants expire on June 15, 2015 and the Series B Warrants expire on June 15, 2011.
Opexa Therapeutics Closes $5.1 Mln Registered Direct Offering - Quick Facts
(RTTNews) - Thursday, Opexa Therapeutics Inc. (OPXA) completed its registered direct offering with several institutional investors to sell 2.55 million units. Each unit consist of one share of Opexa common stock, a five-year Series A warrant to purchase 0.35 of an additional share of Opexa common stock, and a one-year Series B warrant to purchase 0.15 of an additional share of Opexa common stock.
The price of the securities sold was $2.00 per unit, for an aggregate purchase price of $5.1 million. Following to a securities purchase agreement between Opexa and the investors in this offering, the warrants are exercisable at $2.55 per share and are first exercisable on June 15, 2010. The Series A Warrants expire on June 15, 2015 and the Series B Warrants expire on June 15, 2011.
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
